^Honma S, Ito T, Kambegawa A. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man. Chemical & Pharmaceutical Bulletin. February 1985, 33 (2): 760–8. PMID 2861914. doi:10.1248/cpb.33.760.